Tue, April 12, 2022

Matthew Biegler Maintained (ZNTL) at Buy with Decreased Target to $85 on, Apr 12th, 2022

Matthew Biegler of Oppenheimer, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $100 to $85 on, Apr 12th, 2022.

Matthew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $74 on, Monday, April 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022